MADISON,
WI-April 8, 2002-NimbleGen Systems, Inc., a closely held genomics
technology company, announced today the appointments of Steven
W. Smith as Vice President, Bioinformatics and Albrecht W. Frauendorf,
Ph.D., as Senior Director, DNA Array Manufacturing.
Mike Treble,
NimbleGen's President and CEO commented: "NimbleGen has rapidly
grown into an international corporation which both develops and
commercializes world-class DNA microarray products and services.
Steve and Albrecht are key additions as our growth continues since
they deepen our expertise in the fields of Bioinformatics and
DNA Array manufacturing. Their insights will bring tremendous
value to NimbleGen and we are extremely excited to have them join
our staff."
Steven W.
Smith has 12 years of experience in the field of bioinformatics.
Most recently, he formed his own biotech consulting firm, GeneSmith
Informatics, which specialized in bioinformatics support, and
software development and commercialization. Previously, Mr. Smith
served as Manager of Research and Development, and Senior Software
Engineer at Genetics Computer Group. At the company, he led the
development and direction of the Wisconsin Sequence Analysis Package™,
the industry standard software tools for DNA and protein sequence
analysis. In 1990, Mr. Smith served as Director of Computation
at the Harvard Genome Library where he led the assembly and analysis
of the Mycoplasma capricolum genome project.
Mr. Smith
holds a Bachelor of Science in Computer Science from the School
of Engineering, University of Illinois.
Albrecht W. Frauendorf has an interdisciplinary background that
includes chemistry, neurophysiology, statistics and bioinformatics.
Previously, he held three positions at Protogene, Inc., (a DNA
microarray manufacturer): Director, DNA Microarray Operations;
Program Manager, High-Throughput Synthesis; and Senior Scientist,
DNA Microarrays. As Director, Dr. Frauendorf was responsible for
all aspects of technical manufacturing and scale-up of DNA microarrays.
Dr. Frauendorf also developed multivariate statistical methods
for the classification and characterization of CNS active drugs
on the human EEG while working for a German drug development company.
Dr. Frauendorf
did his postdoctoral work at Northwestern University and received
his Ph.D. in Biological Chemistry from the University of Frankfurt.
NimbleGen
Systems, Inc., develops next generation DNA array technologies
that shorten the time it takes to produce arrays from months to
hours. Users are enabled to create their own high density, custom
DNA arrays in their laboratories greatly accelerating the rate
of scientific research and discovery. The Company's core business
strategy is to supply both custom DNA arrays and the systems that
manufacture DNA arrays for academic, biotechnology and pharmaceutical
customers.
